{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:2754",
      "entity_text" : "cilostazol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "In addition, we addressed whether probucol and cilostazol administered in combination attenuate hypercholesterolemia induced exacerbation in ischemic brain injury via anti-inflammatory effects.",
  "reading_complete" : "2020-08-03T13:58:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:57:44Z",
  "trigger" : "attenuate",
  "evidence" : [ "cilostazol administered in combination attenuate hypercholesterolemia-induced exacerbation in ischemic brain injury" ],
  "pmc_id" : "4121353",
  "score" : 0
}